Profile data is unavailable for this security.
About the company
Bioqual, Inc. is engaged in performing contract research services, which is focused on in vivo models of human diseases, including COVID-19, acquired immune deficiency syndrome (AIDS), influenza, Mpox, respiratory syncytial virus (RSV) infection, Flavivirus infections, including zika and dengue, malaria, hepatitis, and cancer. It is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The Company also performs in vitro contract research services. The in vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. It also provides research services in herpes simplex in rodents, filariasis in rhesus macaques, chikungunya in rodents and macaques and dengue in rodents and macaques.
- Revenue in USD (TTM)62.86m
- Net income in USD957.02k
- Incorporated1982
- Employees108.00
- LocationBioqual Inc9600 Medical Center Drive, Suite 101ROCKVILLE 20850-3336United StatesUSA
- Phone+1 (240) 404-7654
- Fax+1 (240) 404-7664
- Websitehttps://www.bioqual.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calcimedica Inc | 0.00 | -34.36m | 61.65m | 14.00 | -- | 4.01 | -- | -- | -26.09 | -26.09 | 0.00 | 1.43 | 0.00 | -- | -- | 0.00 | -132.51 | -63.99 | -155.72 | -72.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.51 | -- | -44.35 | -- |
| Immix Biopharma Inc | 0.00 | -15.43m | 62.03m | 14.00 | -- | 2.85 | -- | -- | -0.8803 | -0.8803 | 0.00 | 0.8235 | 0.00 | -- | -- | 0.00 | -89.54 | -- | -103.83 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
| RetinalGenix Technologies Inc | 0.00 | -2.09m | 62.25m | 0.00 | -- | -- | -- | -- | -0.1205 | -0.1205 | 0.00 | -0.0797 | 0.00 | -- | -- | -- | -929,284.40 | -9,163.75 | -- | -- | -- | -- | -- | -- | -- | -543.50 | -- | -- | -- | -- | 46.58 | -- | -- | -- |
| Kezar Life Sciences Inc | 7.00m | -101.87m | 62.42m | 58.00 | -- | 0.3327 | -- | 8.92 | -1.40 | -1.40 | 0.0965 | 2.58 | 0.0269 | -- | -- | 120,689.70 | -39.12 | -32.54 | -41.41 | -34.09 | -- | -- | -1,455.29 | -4,308.11 | -- | -- | 0.051 | -- | -- | -- | -49.28 | -- | 10.08 | -- |
| Turnstone Biologics Corp | 19.31m | -55.24m | 62.91m | 80.00 | -- | 4.08 | -- | 3.26 | -2.68 | -2.68 | 0.9103 | 0.6672 | -- | -- | -- | 241,325.00 | -- | -- | -- | -- | -- | -- | -285.92 | -- | -- | -- | 0.00 | -- | -73.66 | -- | -78.05 | -- | -- | -- |
| Aileron Therapeutics Inc | 0.00 | -15.73m | 63.82m | 15.00 | -- | 2.67 | -- | -- | -3.39 | -3.39 | 0.00 | 20.12 | 0.00 | -- | -- | 0.00 | -24.58 | -65.99 | -26.17 | -75.37 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.43 | -- | -- | -- |
| Aeon Biopharma Inc | 0.00 | -36.63m | 64.24m | 10.00 | -- | -- | -- | -- | -0.9859 | -0.9859 | 0.00 | -4.12 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.0045 | -- | -- | -- | -- | 30.30 | -- | -- | -- |
| Medicinova Inc | 1.00m | -8.57m | 64.25m | 13.00 | -- | 1.03 | -- | 64.25 | -0.1748 | -0.1748 | 0.0204 | 1.27 | 0.0142 | -- | -- | 76,923.08 | -12.21 | -15.36 | -12.80 | -15.90 | -- | -- | -857.15 | -1,182.54 | -- | -- | 0.00 | -- | -- | -- | 39.08 | -- | 15.87 | -- |
| Mural Oncology PLC | 0.00 | -207.45m | 64.81m | 117.00 | -- | 0.2423 | -- | -- | -12.43 | -12.43 | 0.00 | 15.81 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.29 | -- | -- | -- |
| Bioqual Inc | 62.86m | 957.02k | 64.85m | 108.00 | 67.76 | 1.67 | 18.49 | 1.03 | 1.07 | 1.07 | 70.28 | 43.41 | 1.04 | -- | 2.99 | -- | 1.59 | 8.14 | 1.80 | 9.52 | 14.13 | 19.36 | 1.52 | 7.13 | -- | -- | 0.00 | 21.43 | -5.27 | 11.79 | -84.12 | -25.26 | 1.60 | 10.76 |
| Lantern Pharma Inc | 0.00 | -15.96m | 66.06m | 21.00 | -- | 1.61 | -- | -- | -1.47 | -1.47 | 0.00 | 3.82 | 0.00 | -- | -- | 0.00 | -31.15 | -28.83 | -32.91 | -30.17 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.93 | -- | -- | -- |
| SCYNEXIS Inc | 140.14m | 67.04m | 66.87m | 29.00 | 1.37 | 0.9026 | -- | 0.4772 | 1.29 | 1.29 | 2.90 | 1.96 | 1.30 | 34.76 | 133.41 | 4,832,483.00 | 62.01 | -30.02 | 73.55 | -36.35 | 88.85 | -- | 47.84 | -86.76 | 6.26 | 33.49 | 0.1428 | -- | 2,652.72 | 252.64 | 206.74 | -- | -- | -- |
| enVVeno Medical Corp | 0.00 | -23.52m | 67.25m | 31.00 | -- | 1.46 | -- | -- | -1.96 | -1.96 | 0.00 | 3.47 | 0.00 | -- | -- | 0.00 | -52.09 | -58.43 | -53.82 | -62.76 | -- | -- | -- | -260,799.30 | -- | -- | 0.00 | -- | -- | -- | 4.67 | -- | 21.58 | -- |
| Carisma Therapeutics Inc | 10.63m | -73.50m | 67.30m | 17.00 | -- | 1.41 | -- | 6.33 | -3.70 | -3.70 | 0.411 | 1.15 | 0.0694 | -- | -- | 625,294.10 | -47.96 | -25.47 | -56.78 | -27.87 | -- | -- | -691.39 | -236.32 | -- | -- | 0.0211 | -- | 50.69 | 148.16 | -5,817.86 | -- | -- | -- |
